ClinicalTrials.Veeva

Menu

Therapeutic Recommendations for Nephroblastoma (GFANEPHRO20)

F

French Africa Pediatric Oncology Group

Status

Enrolling

Conditions

Nephroblastoma

Treatments

Other: Data collection

Study type

Observational

Funder types

Other

Identifiers

NCT04423484
GFANEPHRO2020

Details and patient eligibility

About

The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.

Full description

The study is based on results form 2 previous studies carried out by the GFAOP. This study aims to evaluate the capacity of units to follow the recommendations in the protocol. It will look mainly at treatment compliance and outcome for the children treated. The study will also evaluate the improvement in treatment compliance and reporting. This work will help the group to evaluate future needs in participating units and help us adapt treatment programmes to local conditions.

Enrollment

1,000 estimated patients

Sex

All

Ages

6 months to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Unilateral Nephroblastoma Tumor Not previously treated The general health of the child will permit treatment.

.

Exclusion criteria

Bilateral Nephroblastoma tumor Previously treated Disease too advanced Doubt concerning the diagnosis Treatment Refusal

Trial design

1,000 participants in 1 patient group

Children with Nephroblastoma
Description:
All children coming into the participating units with suspected Nephroblastoma.
Treatment:
Other: Data collection

Trial contacts and locations

7

Loading...

Central trial contact

BRENDA Ms MALLON, MSC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems